About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
2021 International Congress on Myeloproliferative Neoplasms
Videos
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
Candidate Drugs for Preventing MPN Progression
By
2021 International Congress on Myeloproliferative Neoplasms
FEATURING
Ronald Hoffman
By
2021 International Congress on Myeloproliferative Neoplasms
FEATURING
Ronald Hoffman
13 views
December 15, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:08
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…
Feat.
A. Tefferi
Featured Video
23:35
University of Colorado Division of Hematology
2024 Updates in PV/ET
Feat.
B. McMahon
Videos
22:32
2021 International Congress on Myeloproliferative Neoplasms
Hereditary Erythrocytosis
Feat.
M. McMullin
21:43
2021 International Congress on Myeloproliferative Neoplasms
Clonal and Nonclonal Thrombocytosis
Feat.
J. Spivak
21:07
2021 International Congress on Myeloproliferative Neoplasms
Persistent Leukocytosis and PV Progression: Prognostic and Therapeut…
Feat.
J. Mascarenhas
22:50
2021 International Congress on Myeloproliferative Neoplasms
JAK2V617F and Clonal Hematopoiesis
Feat.
A. Moliterno
21:36
2021 International Congress on Myeloproliferative Neoplasms
MPN Stem Cell Fitness and the Link to Clinical Outcomes
Feat.
J. Scandura
23:26
2021 International Congress on Myeloproliferative Neoplasms
Candidate Drugs for Preventing MPN Progression
Feat.
R. Hoffman
19:42
2021 International Congress on Myeloproliferative Neoplasms
Hot Topics in Hypereosinophilic Syndrome
Feat.
A. Klion
17:39
2021 International Congress on Myeloproliferative Neoplasms
Novel Agents of Potential Value in the MPN
Feat.
N. Pemmaraju
15:12
2021 International Congress on Myeloproliferative Neoplasms
A Novel Machine Learning-Derived Dynamic Scoring System Predicts Ris…
Feat.
G. Abu-Zeinah
17:41
2021 International Congress on Myeloproliferative Neoplasms
Exploiting Iron Metabolism to Treat Polycythemia Vera
Feat.
Y. Ginzburg
24:03
2021 International Congress on Myeloproliferative Neoplasms
Inflammation in MPNs: Clinical and Therapeutic Aspects
Feat.
H. Hasselbalch
20:56
2021 International Congress on Myeloproliferative Neoplasms
Treatment Approaches for Early MF
Feat.
R. Mesa
32:24
2021 International Congress on Myeloproliferative Neoplasms
New ELN Recommendations for CML
Feat.
R. Hehlmann
17:46
2021 International Congress on Myeloproliferative Neoplasms
Which Published Schemas Are Helpful in MPN Transplant Decisions?
Feat.
S. Giralt
22:47
2021 International Congress on Myeloproliferative Neoplasms
Anticoagulant Management in the MPNs
Feat.
C. Kessler
20:00
2021 International Congress on Myeloproliferative Neoplasms
Are Hematologists Rational?
Feat.
R. Gale
12:42
2021 International Congress on Myeloproliferative Neoplasms
Pediatric MPNs: An Unfamiliar Topic
Feat.
N. Kucine
20:20
2021 International Congress on Myeloproliferative Neoplasms
Role of NGS in the Diagnosis and Prognosis of MPNs
Feat.
A. Vannucchi
21:09
2021 International Congress on Myeloproliferative Neoplasms
Update on the Clinical Status of Commonly Used Drugs in Primary MF
Feat.
S. Verstovsek
